Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · IEX Real-Time Price · USD
40.01
-3.32 (-7.66%)
At close: May 31, 2024, 4:00 PM
39.75
-0.26 (-0.65%)
After-hours: May 31, 2024, 7:51 PM EDT

Legend Biotech Revenue

Legend Biotech had revenue of $342.80M in the twelve months ending March 31, 2024, with 231.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $93.99M with 158.67% year-over-year growth. In the year 2023, Legend Biotech had annual revenue of $285.14M with 143.70% growth.

Revenue (ttm)
$342.80M
Revenue Growth
+231.84%
P/S Ratio
21.28
Revenue / Employee
$187,732
Employees
1,826
Market Cap
7.29B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023285.14M168.14M143.70%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bio-Rad Laboratories 2.61B
Exact Sciences 2.53B
Chemed 2.29B
Penumbra 1.10B
Repligen 607.45M
Ascendis Pharma 357.63M
Revenue Rankings